These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38613802)

  • 21. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target.
    Xu H; Chai S; Wang Y; Wang J; Xiao D; Li J; Xiong N
    CNS Neurosci Ther; 2020 Aug; 26(8):804-814. PubMed ID: 32678519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of a competing endogenous RNA co-expression network as a prognostic marker in glioblastoma.
    Peng Q; Li R; Li Y; Xu X; Ni W; Lin H; Ning L
    J Cell Mol Med; 2020 Nov; 24(22):13346-13355. PubMed ID: 33047898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
    He J; Zeng C; Long Y
    Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma.
    Ge X; Wang Z; Jiang R; Ren S; Wang W; Wu B; Zhang Y; Liu Q
    Int J Biochem Cell Biol; 2021 Oct; 139():106054. PubMed ID: 34390854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
    Huang R; Kong Y; Luo Z; Li Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.
    Li Z; Qian R; Zhang J; Shi X
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30314994
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caspase-4 in glioma indicates deterioration and unfavorable prognosis by affecting tumor cell proliferation and immune cell recruitment.
    Di L; Li M; Lei X; Xie W; Liu G; Wang Y; Zhang W; Zhu WG
    Sci Rep; 2024 Jul; 14(1):17443. PubMed ID: 39075190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
    Li Y; Deng G; Zhang H; Qi Y; Gao L; Tan Y; Hu P; Wang Y; Liu B; Chen Q
    Aging (Albany NY); 2020 Nov; 12(21):22122-22138. PubMed ID: 33186124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
    Liu J; Xu K; Ma L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RGS16 promotes glioma progression and serves as a prognostic factor.
    Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
    CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses.
    Xiao Y; Zhu Z; Li J; Yao J; Jiang H; Ran R; Li X; Li Z
    Aging (Albany NY); 2020 Feb; 12(4):3407-3430. PubMed ID: 32081833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.
    Wu X; Wang Y; Yu T; Nie E; Hu Q; Wu W; Zhi T; Jiang K; Wang X; Lu X; Li H; Liu N; Zhang J; You Y
    Neuro Oncol; 2017 Sep; 19(9):1195-1205. PubMed ID: 28371892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of
    Liu Z; Yang L; Xie Z; Yu H; Gu T; Shi D; Cai N; Zhuo S
    Oncol Res; 2024; 32(5):965-981. PubMed ID: 38686055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.